期刊文献+

卵泡抑素样蛋白-1在川崎病诊断及冠状动脉损害中的作用 被引量:6

Role of follistatin-like protein-1 in Kawasaki disease diagnosis and its coronary arterial injury
下载PDF
导出
摘要 目的探讨卵泡抑素样蛋白-1(FSTL-1)水平与川崎病及冠状动脉损害的关联。方法选择48例川崎病患者为川崎病组,根据有无并发冠状动脉损害,分为川崎病并发冠状动脉损害组(4例)和无并发冠状动脉损害组(44例)。选择同期20例健康儿童作为健康对照组,采用酶联免疫吸附试验检测各组血清中的FSTL-1水平。结果与健康对照组相比,川崎病患者血清FSTL-1水平明显升高,差异有统计学意义(P<0.05);并发冠状动脉损伤的患者其FSTL-1水平明显高于无冠状动脉损害的患者,差异有统计学意义(P<0.05)。结论 FSTL-1水平与川崎病存在一定的相关性,有用于川崎病相关冠状动脉损害诊断的可能。 Objective To investigate the correlation between serum levels of follistatin-like protein-1(FSTL-1)with Kawasaki disease(KD)and its coronary arterial injury.Methods 48 patients with KD were selected as the KD group and divided into the KD disease complicating coronary arterial injury group(4cases)and the KD disease without complicating coronary arterial injury group(44cases).Contemporaneous 20 healthy children were selected as the control group.Serum FSTL-1 levels were measured by ELISA in each group.Results Serum FSTL-1 level in the KD patients was elevated as compared with the control group,the difference was statistically significant(P〈0.05).Serum FSTL-1 level in the KD patients complicating coronary arterial injury was significantly higher than that in the KD patients without complicating coronary arterial injury,the difference was statistically significant(P〈0.05).Conclusion There is certain correlation between serum FSTL-1 level with KD,which has possibility for the application in diagnosing KD related coronary arterial injury.
出处 《检验医学与临床》 CAS 2016年第2期179-180,183,共3页 Laboratory Medicine and Clinic
基金 广东省中山市科技计划项目(2014A1FC011)
关键词 川崎病 卵泡抑素样蛋白-1 冠状动脉损害 Kawasaki disease follistatin-like protein-1 coronary arterial injury
  • 相关文献

参考文献17

  • 1张晓梅,孙景辉.川崎病诊治进展[J].实用儿科临床杂志,2011,26(1):52-55. 被引量:56
  • 2Taubert KA. Nationwidesurvey of Kawasaki disease and acuterheumatic fever[J]. J Pediatr, 1991,119(2):279-282. 被引量:1
  • 3Burns JC, Glode MP. Kawasaki syndrome[J]. Lancet, 2004,364(9433) :533-544. 被引量:1
  • 4Terai M, Shulman ST. Prevalence of coronary artery ab- normalities in Kawasaki disease is highlydependent on gamma globulin dose but independent of salicylate dose [J]. J Pediatr,1997,131(6) :888-893. 被引量:1
  • 5Ayusawa M,Sonobe T,Uemura S,et al. Revision of diag- nostic guidelines for Kawasaki disease (the 5th revised e- dition) [J]. Pediatr Int, 2005,47 (2): 232-234. 被引量:1
  • 6Akagi T,Rose V, Benson LN, et al. Outcome of coronary artery aneurysms after Kawasaki disease[J]. J Pediatr, 1992,121 (5): 689-694. 被引量:1
  • 7Shibanuma M, Mashimo J, Mita A, et al. Cloning from a mouse osteoblastic cell lineof a set of transforming- growth-factor beta 1-regulated genes, one of which seems to encode afollistatin-related polypeptide[J]. Eur J Bio- chem, 1993,217 (1) : 13-19. 被引量:1
  • 8Clutter SD,Wilson DC, Marinov AD, et al. Follistatin-like proteiwl promotes arthritis by upregulating IFN-gamma [J]. J Immunol,2009,182(1) :234-239. 被引量:1
  • 9Miyamae T, Marinov AD, Sowders D, et al. Follistatin-like protein-1 is a novel proinflammatory molecule[J]. JIm munol, 2006,177 (7): 4758-4762. 被引量:1
  • 10Widera C, Horn-Wichmann R, Kempf T, et al. Circulating concentrations of follistatin-like-1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay[J]. Clin Chem, 2009,55(10) : 1794-1800. 被引量:1

二级参考文献31

  • 1孙同文,王乐信,张彦周,李莉,邱春光,杨海波,黄振文.B型利钠肽预测住院心血管病患者近期预后的价值[J].郑州大学学报(医学版),2006,41(1):105-107. 被引量:2
  • 2Cohn JN,Ferrari R,Sharpe N.Cardiac remodeling-concepts and clinical implications:a consensus paper from an international forum on cardiac remodeling.Behalf of an international forum on cardiac remodeling.J Am Coll Cardiol,2000,35:569-582. 被引量:1
  • 3Braunwald E.Biomarkers in heart failure.N Engl J Med,2008,358:2148-2159. 被引量:1
  • 4Oshima Y,Ouchi N,Sato K,et al.Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart.Circulation,2008,117:3099-3108. 被引量:1
  • 5Lara Pezzi E,Felkin LE,Birks EJ,et al.Expression of follistatin-related genes is altered in heart failure.Endocrinology,2008,149:5822-5827. 被引量:1
  • 6Widera C,Horn-Wichmann R,Kempf T,et al.Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay.Clin Chem,2009,55:1794-1800. 被引量:1
  • 7Cockcroft DW,Gault MH.Prediction of creatinine clearance from serum creatinine.Nephron,1976,16:31-41. 被引量:1
  • 8Cheitlin MD,Armstrong WF,Aurigemma GP,et al.ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article:a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography).J Am Coll Cardiol,2003,42:954-970. 被引量:1
  • 9Devereux RB,Alonso DR,Lutas EM,et al.Echocar-diographic assessment of left ventricular hypertrophy:comparison to necropsy findings.Am J Cardiol,1986,57:450-458. 被引量:1
  • 10Velagaleti RS,Gona P,Levy D,et al.Relations of biomarkers representing distinct biological pathways to left ventricular geometry.Circulation,2008,118:2252-2258. 被引量:1

共引文献71

同被引文献109

  • 1Shibanuma M, Mashimo J, Mita A, et al. Cloning from a mouse osteoblastic cell line of a set of transforming-growth- factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide[J]. Eur J Biochem, 1998,217 (1) :13-19. 被引量:1
  • 2Geng Y, Dong Y, Yu M, et al. Follistatin-like 1 (Fstll) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development[J]. Proc Natl Aead Sei U S A, 2011,108(17) : 7058-7063. 被引量:1
  • 3Sylva M, Li VS, Buffing AA, et al. The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis [J]. PLoS One, 2011,6(8):e22616. 被引量:1
  • 4Tanaka M, Ozaki S, Osakada F, et al. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases[J]. Int Immunol, 1998,10(9) .,1305-1314. 被引量:1
  • 5Wilson DC, Marinov AD, Blair HC, et al. Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis[J]. Arthritis Rheum, 2010,62(8) : 2510- 2516. 被引量:1
  • 6Chaly Y, Fu Y, Marinov A, et al. Follistatin-like protein 1 enhances NLRP3 inflammasome-mediated IL-lbeta secretion from monocytes and macrophages[J]. Eur J Immunol, 2014, 44(5) : 1467-1479. 被引量:1
  • 7Yang Y, Liu J, Mao H, et al. The expression pattern of Follistatin-like 1 in mouse central nervous system development[J]. Gene Expr Patterns, 2009,9(7) :532-540. 被引量:1
  • 8Wang Y, Li D, Xu N, et al. Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis[J]. Arthritis Res Ther, 2011,13(6) :R193. 被引量:1
  • 9Li D, Wang Y, Xu N, et al. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis [J ]. Arthritis Res Ther, 2011,13(1) :R17. 被引量:1
  • 10Miller M, Beppu A, Rosenthal P, et al. Fstll promotes asthmatic airway remodeling by inducing oncostatin M[J]. J Immunol, 2015,195(8) :3546-3556. 被引量:1

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部